RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

74 hedge funds and large institutions have $1.01B invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.38M
Puts
$67K
Net Calls
Net Calls Change

Top Buyers

1 +$48.3M
2 +$25.7M
3 +$9.65M
4
Norges Bank
Norges Bank
Norway
+$8.44M
5
FAM
Fred Alger Management
New York
+$6.82M

Top Sellers

1 -$43.9M
2 -$23.8M
3 -$11.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.23M
5
PA
Perceptive Advisors
New York
-$5.58M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$145M
2
$129M
3
$125M
4
$85.4M
5
$73.1M
6
$73.1M
7
$69.3M
8
$47.2M
9
$24.5M
10
$23.9M
11
$22M
12
$20.6M
13
$17.5M
14
$14.5M
15
$13M
16
$11.9M
17
$9.9M
18
$9.88M
19
$9.1M
20
$7.91M
21
$7.91M
22
$6.82M
23
$6.04M
24
$5.32M
25
$4.65M